RecruitingNCT07598747
Prospective Study for the Development, Validation and Confirmation of a Multi-Cancer Early Detection Platform Through Whole-Genome Sequencing Analysis of Circulating DNA in Cancer and Non-Cancer Subjects
Sponsor
Chang Gon Kim
Enrollment
6,000 participants
Start Date
Oct 14, 2024
Study Type
OBSERVATIONAL
Conditions
Summary
This is a prospective, multi-center clinical study of Multi-Cancer Early Detection (MCED) testing in cancer patients and healthy volunteers. This study was designed to establish a clinical and molecular database using circulating DNA from both cancer patients and non-cancer participants, advance and validate an artificial intelligence platform capable of detecting various types of cancer at an early stage, and evaluate its performance.
Eligibility
Min Age: 19 Years
Inclusion Criteria8
- Adults aged 19 years or older
- Individuals who understand the study and voluntarily provide informed consent.
- (only for cancer participants) Participants with newly diagnosed solid tumors (Stage I-IV, including brain tumors) or hematologic malignancies who:
- Have a histologically confirmed diagnosis (including bone marrow biopsy), or
- Are highly suspected of having cancer based on clinical and/or radiologic evaluation and are scheduled for surgical resection after blood collection; and
- Have not yet initiated any treatment (chemotherapy, targeted therapy, hormonal therapy, immunotherapy, radiotherapy, surgical resection, etc.).
- (only for non-cancer participants) Individuals with no prior history of cancer.
- (only for non-cancer participants) Individuals scheduled to undergo chest and/or abdominal CT or MRI imaging.
Exclusion Criteria6
- Pregnancy (self-reported pregnancy status).
- Individuals for whom blood collection is deemed difficult by the investigator.
- Individuals with a history of infection with HIV, HTLV, or syphilis.
- (only for non-cancer participants) Individuals diagnosed with another malignancy within the past 5 years (exceptions: non-melanoma skin cancer, in-situ malignancies, thyroid cancer, and cervical intraepithelial neoplasia treated with curative intent).
- (only for non-cancer participants) Individuals with cancer of unknown primary origin.
- (only for non-cancer participants) Individuals with synchronous or metachronous multiple primary cancers.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07598747
Related Trials
Feasibility and Acceptability of Collecting Sociodemographic Data in CCTG Trials
NCT073904353 locations
A Digital Art Activity to Enhance Self-Disclosure and the Detection of Psycho-social Distress in Adult Cancer Patients
NCT061271211 location
Preserving Physical Function in Older Adults With Cancer: Impact of an Optimizing Nutrition Intervention Applied Before and After Surgery
NCT059122571 location
xDRIVE for Florida-based Cancer Patients
NCT071673812 locations
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
NCT065827841 location